Aarhus Universitets segl

English

Du er her: AU » Om AU » Organisation » HPV-vaccination til kvinder

Om AU

HPV-vaccination til kvinder

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

Standard

HPV-vaccination til kvinder. / Høgh, Lisa Maria Bæk; Eriksen, Dina Overgaard; Hjorth, Ina Marie Dueholm et al.
I: Ugeskrift for Laeger, Bind 184, Nr. 21, V11210891, 23.05.2022.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

Harvard

Høgh, LMB, Eriksen, DO, Hjorth, IMD & Hammer, A 2022, 'HPV-vaccination til kvinder', Ugeskrift for Laeger, bind 184, nr. 21, V11210891.

APA

Høgh, L. M. B., Eriksen, D. O., Hjorth, I. M. D., & Hammer, A. (2022). HPV-vaccination til kvinder. Ugeskrift for Laeger, 184(21), artikel V11210891.

CBE

Høgh LMB, Eriksen DO, Hjorth IMD, Hammer A. 2022. HPV-vaccination til kvinder. Ugeskrift for Laeger. 184(21):Article V11210891.

MLA

Høgh, Lisa Maria Bæk et al. "HPV-vaccination til kvinder". Ugeskrift for Laeger. 2022. 184(21).

Vancouver

Høgh LMB, Eriksen DO, Hjorth IMD, Hammer A. HPV-vaccination til kvinder. Ugeskrift for Laeger. 2022 maj 23;184(21):V11210891.

Author

Høgh, Lisa Maria Bæk ; Eriksen, Dina Overgaard ; Hjorth, Ina Marie Dueholm et al. / HPV-vaccination til kvinder. I: Ugeskrift for Laeger. 2022 ; Bind 184, Nr. 21.

Bibtex

@article{77a3bd069d8c40b693bf63f07ffe0143,
title = "HPV-vaccination til kvinder",
abstract = "HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.",
author = "H{\o}gh, {Lisa Maria B{\ae}k} and Eriksen, {Dina Overgaard} and Hjorth, {Ina Marie Dueholm} and Anne Hammer",
year = "2022",
month = may,
day = "23",
language = "Dansk",
volume = "184",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Den Almindelige Danske L{\ae}geforening",
number = "21",

}

RIS

TY - JOUR

T1 - HPV-vaccination til kvinder

AU - Høgh, Lisa Maria Bæk

AU - Eriksen, Dina Overgaard

AU - Hjorth, Ina Marie Dueholm

AU - Hammer, Anne

PY - 2022/5/23

Y1 - 2022/5/23

N2 - HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.

AB - HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.

UR - http://www.scopus.com/inward/record.url?scp=85131337518&partnerID=8YFLogxK

M3 - Tidsskriftartikel

C2 - 35656616

AN - SCOPUS:85131337518

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 21

M1 - V11210891

ER -